EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pericytes Modulate Third‐Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR‐Mutated Lung Cancer Cells Through IL32‐β5‐Integrin Paracrine Signaling

Cheng Huang, Xi Huang, Xiaoyi Qiu, Xiangzhan Kong, Chunmiao Wu, Xue Jiang, Mingkang Yao, Minghui Wang, Liangping Su, Cui Lv, Ping-Pui Wong iD

Advanced Science · 2024

DOI: 10.1002/advs.202405130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Cheng Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Ya…. Hauptthemen laut MEDLINE: Lung Neoplasms, Pericytes, ErbB Receptors, Paracrine Communication. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Sun Yat-sen University, Guangdong Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EGFR‐mutated lung cancer patients sometimes display restricted responses to third‐generation tyrosine kinase inhibitors (TKIs), potentially attributable to undervalued input from stromal cells, notably pericytes (PCs). The study shows that PCs isolated from EGFR‐mutated patients have a unique secretome profile, notably secreting IL32 and affecting signaling pathways and biological processes linked to TKI sensitivity. Clinical evidence, supported by single‐cell RNA sequencing and multiplex immunostaining of tumor tissues, confirms the presence of IL32‐expressing pericytes closely interacting with β5‐integrin‐expressing cancer cells in EGFR‐mutated patients, impacting therapeutic response and prognosis. Co‐culture and conditioned medium experiments demonstrate that PCs reduce TKI effectiveness in EGFR‐mutated cancer cells, a reversible phenomenon through silencing IL32 expression in PCs or depleting the IL32 receptor β5‐integrin on cancer cells, thereby restoring cancer cell sensitivity. Mechanistically, it is shown that YY1 signaling upregulates IL32 secretion in PCs, subsequently activating the β5‐integrin‐Src‐Akt pathway in EGFR‐mutated cancer cells, contributing to their TKI sensitivity. In animal studies, co‐injection of cancer cells with PCs compromises TKI effectiveness, independently of blood vessel functions, while inhibition of β5‐integrin restores tumor cell sensitivity. Overall, the findings highlight direct crosstalk between cancer cells and pericytes, impacting TKI sensitivity via IL32‐β5‐integrin paracrine signaling, proposing an enhanced therapeutic approach for EGFR‐mutated patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPericytesErbB ReceptorsParacrine CommunicationProtein Kinase InhibitorsHumansAnimalsMiceInterleukinsCell Line, TumorMutationSignal TransductionDisease Models, AnimalTyrosine Kinase InhibitorsIntegrins

Stichwörter der Autor:innen

non‐small cell lung cancerpericytestyrosine kinase inhibitor sensitivityβ5‐integrin

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanInterleukinsITGA5 protein, humanTyrosine Kinase InhibitorsIntegrins

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, Ch…
  • Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Department of Respiratory Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Guangdong Provincial Key Laboratory of Urological Diseases, Guangzhou Medical University, Guangzhou, 510120, China.

ORCID-Profile: Ping-Pui Wong

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities, Sun Yat-sen University
  • Guangdong Science and Technology Department
  • Guangdong Basic and Applied Basic Research Foundation
  • Open Project of Guangdong Provincial Key Laboratory of Urological Diseases
  • China Postdoctoral Science Foundation
  • Guangdong Provincial Department of Science and Technology

Zitieren

APA

Huang, C., Huang, X., Qiu, X., Kong, X., Wu, C., Jiang, X., Yao, M., Wang, M., Su, L., Lv, C., & Wong, P. P. (2024). Pericytes Modulate Third‐Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR‐Mutated Lung Cancer Cells Through IL32‐β5‐Integrin Paracrine Signaling. Advanced Science. https://doi.org/10.1002/advs.202405130

Vancouver

Huang C, Huang X, Qiu X, Kong X, Wu C, Jiang X, et al. Pericytes Modulate Third‐Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR‐Mutated Lung Cancer Cells Through IL32‐β5‐Integrin Paracrine Signaling. Advanced Science. 2024. doi:10.1002/advs.202405130

BibTeX
@article{Huang2024,
  author = {Huang, Cheng and Huang, Xi and Qiu, Xiaoyi and Kong, Xiangzhan and Wu, Chunmiao and Jiang, Xue and Yao, Mingkang and Wang, Minghui and Su, Liangping and Lv, Cui and Wong, Ping-Pui},
  title = {Pericytes Modulate Third‐Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR‐Mutated Lung Cancer Cells Through IL32‐β5‐Integrin Paracrine Signaling},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202405130}
}
Kostenlos starten →